Pear Therapeutics, Inc.

Pear Therapeutics, Inc.verified

PEAR

Price:

$0.0292

Market Cap:

$4.09M

Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.[Read more]

Industry

Medical - Healthcare Information Services

IPO Date

2021-03-31

Stock Exchange

NASDAQ

Ticker

PEAR

The Enterprise Value as of September 2024 (TTM) for Pear Therapeutics, Inc. (PEAR) is -6605182.00

According to Pear Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -6605182.00. This represents a change of -102.09% compared to the average of 316.35M of the last 4 quarters.

Pear Therapeutics, Inc. (PEAR) Historical Enterprise Value (quarterly & annually)

How has PEAR Enterprise Value performed in the past?

The mean historical Enterprise Value of Pear Therapeutics, Inc. over the last ten years is 843.06M. The current -6605182.00 Enterprise Value has changed -178.35% with respect to the historical average. Over the past ten years (40 quarters), PEAR's Enterprise Value was at its highest in in the December 2021 quarter at 685.46M. The Enterprise Value was at its lowest in in the December 2020 quarter at -84555000.00.

Quarterly (TTM)
Annual

Average

843.06M

Median

926.75M

Minimum

152.98M

Maximum

1.37B

Pear Therapeutics, Inc. (PEAR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pear Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Enterprise Value = 1.37B

Minimum Annual Increase = -72.69%

Minimum Annual Enterprise Value = 152.98M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2022152.98M-72.69%
2021560.06M-56.70%
20201.29B-5.29%

Pear Therapeutics, Inc. (PEAR) Average Enterprise Value

How has PEAR Enterprise Value performed in the past?

The current Enterprise Value of Pear Therapeutics, Inc. (PEAR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

668.83M

5-year avg

843.06M

10-year avg

843.06M

Pear Therapeutics, Inc. (PEAR) Enterprise Value vs. Peers

How is PEAR’s Enterprise Value compared to its peers?

Pear Therapeutics, Inc.’s Enterprise Value is less than Healthcare Triangle, Inc. (5.66M), less than Bullfrog AI Holdings, Inc. Common Stock (13.65M), less than EUDA Health Holdings Limited (107.74M), less than Mangoceuticals, Inc. (7.83M), less than Minerva Surgical, Inc. (32.53M), less than FOXO Technologies Inc. (15.04M), less than ETAO International Co., Ltd. (9.78M), greater than Science 37 Holdings, Inc. (-21164022.00), less than Aclarion, Inc. (1.25M), less than Augmedix, Inc. (111.23M), less than Aclarion, Inc. (1.25M), greater than Akili, Inc. (-15651464.00),

Build a custom stock screener for Pear Therapeutics, Inc. (PEAR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pear Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pear Therapeutics, Inc. (PEAR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pear Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Pear Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Pear Therapeutics, Inc. (PEAR)?

What is the 3-year average Enterprise Value for Pear Therapeutics, Inc. (PEAR)?

What is the 5-year average Enterprise Value for Pear Therapeutics, Inc. (PEAR)?

How does the current Enterprise Value for Pear Therapeutics, Inc. (PEAR) compare to its historical average?